ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,460,226, issued on Nov. 4, was assigned to The Trustees of the University of Pennsylvania (Philadelphia).

"Compositions and methods for treating duchenne muscular dystrophy" was invented by Hansell Stedman (Norristown, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are triple-splice mutants of dystrophin or utrophin and methods of use thereof for treating Duchenne Muscular Dystrophy. Also provided are viral vectors which comprise a nucleic acid encoding a triple-splice mutant dystrophin or utrophin under the control of regulatory elements direct expression thereof. Compositions are also provided which contain such viral vectors formu...